Order Article Reprints

Ando Y, Kawaoka T, Kosaka M, Shirane Y, Johira Y, Miura R, Murakami S, Yano S, Amioka K, Naruto K, et al. Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice. Cancers. 2021; 13(16):3958. https://doi.org/10.3390/cancers13163958

Ando, Yuwa, Tomokazu Kawaoka, Masanari Kosaka, Yuki Shirane, Yusuke Johira, Ryoichi Miura, Serami Murakami, Shigeki Yano, Kei Amioka, Kensuke Naruto, and et al. 2021. "Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice" Cancers 13, no. 16: 3958. https://doi.org/10.3390/cancers13163958

Ando, Y., Kawaoka, T., Kosaka, M., Shirane, Y., Johira, Y., Miura, R., Murakami, S., Yano, S., Amioka, K., Naruto, K., Kosaka, Y., Uchikawa, S., Kodama, K., Fujino, H., Nakahara, T., Ono, A., Murakami, E., Yamauchi, M., Okamoto, W., ... Aikata, H. (2021). Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice. Cancers, 13(16), 3958. https://doi.org/10.3390/cancers13163958